Immix Biopharma Inc — Financial Statements (NASDAQ:IMMX) | MetaTrader

Open full chart

뉴스

Immix Biopharma, FDA 혁신 치료제 지정 후 주가 상승

Immix Biopharma stock climbs after FDA grants breakthrough therapy status

FDA grants breakthrough therapy status to ImmixBio’s amyloidosis drug

Immix Biopharma (IMMX) Shares Slip As Investors Focus On Plans To Offer And Sell $750 Million In Securities - Immix Biopharma (NASDAQ:IMMX)

Immix Biopharma: Thesis Playing Out; Thoughts On Valuation And Competition (IMMX)

Immix Biopharma CFO, 주식 5천 달러 상당 매수

Immix Biopharma (IMMX) CEO, 주식 4975달러 매수

Immix Biopharma CFO Gabriel Morris buys $5k in shares

Ilya Rachman, Immix Biopharma CEO, buys $4975 in shares

Immix Biopharma 목표 주가, H.C. Wainwright, 12달러로 상향

Immix Biopharma stock price target raised to $12 from $8 at H.C. Wainwright

Immix Biopharma, 9370만 달러 공모 완료